Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer
Top Cited Papers
- 15 February 2003
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (4), 602-606
- https://doi.org/10.1200/jco.2003.07.071
Abstract
Purpose: Although clinical trials have clearly demonstrated the benefits of tamoxifen in women with primary breast cancer, little is known about how this drug is actually used in the general popula...Keywords
This publication has 39 references indexed in Scilit:
- Biologic Activity of Tamoxifen at Low Doses in Healthy WomenJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive TumorsJNCI Journal of the National Cancer Institute, 1996
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.Journal of Clinical Oncology, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER: Analysis at Six Years by Nolvadex Adjuvant Trial OrganisationThe Lancet, 1985
- Intentional Prescription Nonadherence (Noncompliance) by the ElderlyJournal of the American Geriatrics Society, 1982